CLEC16A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.116100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.182200E-02
Normal-vs-Stage2
2.814000E-02
Normal-vs-Stage3
1.841840E-02
Normal-vs-Stage4
1.569220E-01
Stage1-vs-Stage2
7.214600E-01
Stage1-vs-Stage3
1.215630E-01
Stage1-vs-Stage4
8.407400E-01
Stage2-vs-Stage3
3.921900E-02
Stage2-vs-Stage4
9.602400E-01
Stage3-vs-Stage4
2.341200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.457650E-02
Normal-vs-AfricanAmerican
1.416240E-01
Normal-vs-Asian
5.443000E-03
Caucasian-vs-AfricanAmerican
5.828600E-01
Caucasian-vs-Asian
5.718600E-01
AfricanAmerican-vs-Asian
3.804800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.934200E-02
Normal-vs-Female
1.834250E-02
Male-vs-Female
4.874800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.672300E-02
Normal-vs-Age(41-60Yrs)
3.946500E-02
Normal-vs-Age(61-80Yrs)
2.568400E-02
Normal-vs-Age(81-100Yrs)
7.997900E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.182400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.596800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.301600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.697220E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.135220E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.586200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.199500E-03
Normal-vs-Daily Drinker
4.196000E-02
Normal-vs-Weekly Drinker
4.897600E-02
Normal-vs-Occasional Drinker
3.493900E-02
Normal-vs-Social Drinker
6.737700E-03
Non Drinker-vs-Daily Drinker
5.446200E-01
Non Drinker-vs-Weekly Drinker
2.122200E-01
Non Drinker-vs-Occasional Drinker
2.898400E-01
Non Drinker-vs-Social Drinker
1.729170E-01
Daily Drinker-vs-Weekly Drinker
5.492600E-01
Daily Drinker-vs-Occasional Drinker
6.952600E-01
Daily Drinker-vs-Social Drinker
4.780800E-01
Weekly Drinker-vs-Occasional Drinker
7.995600E-01
Weekly Drinker-vs-Social Drinker
9.699000E-01
Occasional Drinker-vs-Social Drinker
7.953400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.059600E-02
Normal-vs-Grade 2
5.376800E-03
Normal-vs-Grade 3
1.122290E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.999030E-01
Grade 1-vs-Grade 3
2.084000E-01
Grade 1-vs-Grade 4
9.059600E-02
Grade 2-vs-Grade 3
9.801600E-01
Grade 2-vs-Grade 4
5.376800E-03
Grade 3-vs-Grade 4
1.122290E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.044140E-02
Normal-vs-NonDiabetic
2.547800E-02
Diabetic-vs-NonDiabetic
1.296200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.400810E-01
Normal-vs-NoPancreatitis
1.823950E-02
Pancreatitis-vs-NoPancreatitis
5.057700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.103100E-03
Normal-vs-N1
3.514400E-02
N0-vs-N1
3.499000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.316780E-01
Normal-vs-TP53-NonMutant
2.594100E-02
TP53-Mutant-vs-TP53-NonMutant
3.040600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
